Cellectis Financial Statements From 2010 to 2025

CLLS Stock  USD 1.82  0.11  5.70%   
Cellectis' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Cellectis' valuation are provided below:
Gross Profit
54.7 M
Profit Margin
(1.11)
Market Capitalization
184.7 M
Enterprise Value Revenue
0.6883
Revenue
54.7 M
There are over one hundred nineteen available fundamental signals for Cellectis SA, which can be analyzed over time and compared to other ratios. All traders should validate Cellectis' prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 144.1 M in 2025. Enterprise Value is likely to drop to about 94.9 M in 2025

Cellectis Total Revenue

31.47 Million

Check Cellectis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellectis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 20.9 M, Interest Expense of 7.8 M or Selling General Administrative of 29.7 M, as well as many indicators such as Price To Sales Ratio of 3.47, Dividend Yield of 0.0 or PTB Ratio of 1.1. Cellectis financial statements analysis is a perfect complement when working with Cellectis Valuation or Volatility modules.
  
Build AI portfolio with Cellectis Stock
Check out the analysis of Cellectis Correlation against competitors.

Cellectis Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets279.2 M383.5 M289.2 M
Slightly volatile
Other Current Liabilities11.2 M22.2 M11.4 M
Slightly volatile
Total Current Liabilities174.6 M166.3 M71.3 M
Slightly volatile
Total Stockholder Equity170.6 M131 M174.5 M
Slightly volatile
Property Plant And Equipment Net43.6 M75.9 M46.8 M
Slightly volatile
Cash182.1 M143.3 M189.1 M
Slightly volatile
Non Current Assets Total58.8 M96.5 M60.6 M
Slightly volatile
Cash And Short Term Investments193.4 M260.3 M201.3 M
Slightly volatile
Net Receivables15.9 M23 M15.9 M
Slightly volatile
Common Stock Total Equity2.4 M2.5 M22.1 M
Slightly volatile
Common Stock Shares Outstanding95.1 M90.6 M41.2 M
Slightly volatile
Liabilities And Stockholders Equity279.2 M383.5 M289.2 M
Slightly volatile
Non Current Liabilities Total100 M95.3 M44.3 M
Slightly volatile
Total Liabilities265.1 M252.5 M114.4 M
Slightly volatile
Property Plant And Equipment Gross175.6 M167.2 M65.5 M
Slightly volatile
Total Current Assets220.5 M287.1 M228.6 M
Slightly volatile
Common Stock5.6 M5.9 M22.6 M
Slightly volatile
Accounts Payable17.9 M18.7 M16.9 M
Slightly volatile
Short and Long Term Debt Total96 M91.5 M44.8 M
Slightly volatile
Intangible Assets1.1 M1.1 M7.4 M
Slightly volatile
Short Term Debt13.9 M13.2 M5.1 M
Slightly volatile
Other Liabilities11.3 M10.8 M4.3 M
Slightly volatile
Long Term Debt46.2 M44 M16 M
Slightly volatile
Long Term Investments4.4 M7.5 M3.4 M
Slightly volatile
Short and Long Term Debt2.7 M4.8 M2.8 M
Very volatile
Property Plant Equipment130.3 M124.1 M56.1 M
Slightly volatile
Short Term Investments122.9 M117.1 M30.1 M
Slightly volatile
Long Term Debt Total56.2 M53.5 M21.5 M
Slightly volatile
Capital Surpluse731 M970 M671.2 M
Slightly volatile
Capital Lease Obligations44.3 M42.6 M25.5 M
Slightly volatile
Net Invested Capital198 M179.9 M252.8 M
Slightly volatile
Non Current Liabilities Other837.9 K882 K1.6 M
Slightly volatile
Net Working Capital176.8 M120.8 M243.9 M
Slightly volatile
Capital Stock3.8 M5.9 M3.2 M
Slightly volatile

Cellectis Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization20.9 M19.9 M10.8 M
Slightly volatile
Interest Expense7.8 M7.5 M3.1 M
Slightly volatile
Selling General Administrative29.7 M17.6 M30.1 M
Very volatile
Total Revenue31.5 M41.5 M30.8 M
Pretty Stable
Gross Profit23.3 M21.6 M22.4 M
Very volatile
Other Operating Expenses91.6 M108.8 M94.1 M
Slightly volatile
Cost Of Revenue20.9 M19.9 M9.3 M
Slightly volatile
Total Operating Expenses83.5 M89.7 M85.7 M
Slightly volatile
Selling And Marketing Expenses1.7 M1.8 M9.2 M
Slightly volatile
Research Development68.8 M90.5 M63 M
Slightly volatile
Non Recurring2.2 M2.4 M2.9 M
Slightly volatile
Interest Income11.8 M11.3 M6.1 M
Pretty Stable
Reconciled Depreciation13.2 M19.8 M8.3 M
Slightly volatile

Cellectis Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based CompensationM3.2 M15.3 M
Very volatile
Begin Period Cash Flow164 M136.7 M169.4 M
Slightly volatile
Depreciation20.8 M19.8 M10.9 M
Slightly volatile
Capital Expenditures3.7 M3.8 MM
Pretty Stable
End Period Cash Flow174.2 M143.3 M180.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.473.653931.3066
Pretty Stable
PTB Ratio1.11.15743.0942
Slightly volatile
Days Sales Outstanding192203838
Slightly volatile
Book Value Per Share1.391.45834.7712
Very volatile
Average Payables16.2 M14.5 M14 M
Slightly volatile
Stock Based Compensation To Revenue0.07250.07631.0326
Slightly volatile
Capex To Depreciation0.180.19361.4066
Very volatile
PB Ratio1.11.15743.0942
Slightly volatile
EV To Sales2.292.406120.6815
Pretty Stable
Inventory Turnover0.06960.07337.2624
Slightly volatile
Days Of Inventory On Hand4.2 KK1.4 K
Slightly volatile
Payables Turnover0.0330.03480.339
Pretty Stable
Sales General And Administrative To Revenue0.40.42412.5091
Slightly volatile
Average Inventory124.2 K130.7 K236.6 K
Slightly volatile
Research And Ddevelopement To Revenue2.072.18139.3934
Slightly volatile
Capex To Revenue0.0880.09260.3058
Slightly volatile
Cash Per Share4.112.8975.4308
Very volatile
Days Payables Outstanding8.9 K8.5 K3.3 K
Slightly volatile
Intangibles To Total Assets0.00280.00290.0644
Slightly volatile
Current Ratio3.281.72654.1054
Very volatile
Receivables Turnover1.711.80175.428
Pretty Stable
Shareholders Equity Per Share1.391.45834.5254
Very volatile
Debt To Equity0.730.6980.4384
Pretty Stable
Capex Per Share0.04060.04280.2117
Very volatile
Average Receivables8.2 M16.3 M16.4 M
Very volatile
Revenue Per Share0.440.46190.8872
Slightly volatile
Interest Debt Per Share0.781.10081.1223
Pretty Stable
Debt To Assets0.250.23850.1523
Slightly volatile
Graham Number0.270.280.2916
Slightly volatile
Operating Cycle1922031.2 K
Slightly volatile
Price Book Value Ratio1.11.15743.0942
Slightly volatile
Days Of Payables Outstanding8.9 K8.5 K3.3 K
Slightly volatile
Company Equity Multiplier1.682.92712.221
Very volatile
Long Term Debt To Capitalization0.130.25130.1467
Pretty Stable
Total Debt To Capitalization0.430.41110.2354
Slightly volatile
Debt Equity Ratio0.730.6980.4384
Pretty Stable
Quick Ratio3.261.72654.0704
Very volatile
Net Income Per E B T0.620.780.844
Pretty Stable
Cash Ratio0.820.86163.3692
Very volatile
Days Of Inventory Outstanding4.2 KK1.4 K
Slightly volatile
Days Of Sales Outstanding192203838
Slightly volatile
Price To Book Ratio1.11.15743.0942
Slightly volatile
Fixed Asset Turnover0.520.54712.5828
Slightly volatile
Debt Ratio0.250.23850.1523
Slightly volatile
Price Sales Ratio3.473.653931.3066
Pretty Stable
Asset Turnover0.180.10820.1421
Slightly volatile
Gross Profit Margin0.0260.02740.6299
Slightly volatile
Price Fair Value1.11.15743.0942
Slightly volatile

Cellectis Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap144.1 M151.7 M454.7 M
Very volatile
Enterprise Value94.9 M99.9 M312.1 M
Very volatile

Cellectis Fundamental Market Drivers

Cash And Short Term Investments260.3 M

Cellectis Upcoming Events

13th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Cellectis Financial Statements

Cellectis shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Cellectis investors may analyze each financial statement separately, they are all interrelated. The changes in Cellectis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellectis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue112.2 M117.8 M
Total Revenue41.5 M31.5 M
Cost Of Revenue19.9 M20.9 M
Stock Based Compensation To Revenue 0.08  0.07 
Sales General And Administrative To Revenue 0.42  0.40 
Research And Ddevelopement To Revenue 2.18  2.07 
Capex To Revenue 0.09  0.09 
Revenue Per Share 0.46  0.44 
Ebit Per Revenue(1.43)(1.51)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.